Fintel reports that on May 19, 2023, Oppenheimer maintained coverage of Modular Medical (OTC:MODD) with a Outperform recommendation.
Analyst Price Forecast Suggests 444.66% Upside
As of May 11, 2023, the average one-year price target for Modular Medical is 5.61. The forecasts range from a low of 5.05 to a high of $6.30. The average price target represents an increase of 444.66% from its latest reported closing price of 1.03.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Modular Medical is 0MM. The projected annual non-GAAP EPS is -1.59.
What is the Fund Sentiment?
There are 16 funds or institutions reporting positions in Modular Medical. This is unchanged over the last quarter. Average portfolio weight of all funds dedicated to MODD is 0.05%, a decrease of 24.65%. Total shares owned by institutions decreased in the last three months by 3.69% to 1,527K shares.
What are Other Shareholders Doing?
Sio Capital Management holds 689K shares representing 6.31% ownership of the company. No change in the last quarter.
Solas Capital Management holds 452K shares representing 4.14% ownership of the company. No change in the last quarter.
Opaleye Management holds 184K shares representing 1.68% ownership of the company. In it's prior filing, the firm reported owning 245K shares, representing a decrease of 33.51%. The firm decreased its portfolio allocation in MODD by 53.23% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 107K shares representing 0.98% ownership of the company. No change in the last quarter.
Bank Of America holds 25K shares representing 0.23% ownership of the company. In it's prior filing, the firm reported owning 25K shares, representing a decrease of 0.05%. The firm decreased its portfolio allocation in MODD by 83.33% over the last quarter.
Key filings for this company:
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
